Rezolute is a biopharmaceutical company dedicated to developing transformative therapies for patients with severe metabolic and endocrine disorders, particularly those suffering from hyperinsulinism. Our lead therapy, RZ358 (ersodetug), targets both congenital and tumor-related forms of hypoglycemia, showcasing our commitment to addressing rare and complex medical conditions with innovative solutions.
No jobs found. Subscribe below to get notified when we find something for you.
Searching